Join Now

Author Archives: admin

BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention

The Utah Pavilion will serve as a gathering place to help convention attendees discover the state’s vibrant life sciences industry and the sector’s unique culture of collaboration that drives innovation.

Posted in BioUtah News | Comments Off on BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention

nView Medical Surpasses 1,000 Surgeries

nView medical announced that its nView s1 system has surpassed 1,000 surgeries, marking an important milestone in the clinical use of the company’s intraoperative 3D imaging and navigation technology.

Posted in BioUtah News | Comments Off on nView Medical Surpasses 1,000 Surgeries

NanoKar Therapeutics Receives Funding From the University of Utah Launchpad Seed Fund to Advance Next-Generation CAR-T Cell Therapy Platform

University of Utah Launchpad Seed Fund award to support translational validation of NanoKar’s ITAM optimization platform, including CAR-T persistence and activity in solid tumor models.

Posted in BioUtah News | Comments Off on NanoKar Therapeutics Receives Funding From the University of Utah Launchpad Seed Fund to Advance Next-Generation CAR-T Cell Therapy Platform

Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358

Expanded collaboration adds manufacturing capacity, strengthens redundancy, and supports later-stage development planning for Ratio’s lead FAP-targeted radiotherapeutic candidate.

Posted in BioUtah News | Comments Off on Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358

UNIVERSITY OF UTAH HEALTH DEDICATES JAMES LEVOY SORENSON CENTER FOR MEDICAL INNOVATION

Apr 14, 2026 University of Utah Health dedicated the James LeVoy Sorenson Center for Medical Innovation, a $50-million world-class hub designed to accelerate transformative research, medical device development, and life science training. Made possible by a generous $22 million lead gift from the Sorenson Legacy Foundation, the state-of-the-art facility serves as the new heart of […]

Posted in Policy News | Comments Off on UNIVERSITY OF UTAH HEALTH DEDICATES JAMES LEVOY SORENSON CENTER FOR MEDICAL INNOVATION

Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her again shortly after she delivered her first child. The visit was scheduled as a routine six-week newborn evaluation. As is common in primary care, the encounter extended beyond the infant to include the mother’s well-being. During the […]

Posted in BioUtah News | Comments Off on Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings

Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The University of Utah has been named to the National Academy of Inventors’ (NAI) 2025 Top 100 U.S. Universities Granted U.S. Utility Patents list, further reinforcing its position as a national leader in research, innovation, and commercialization. This […]

Posted in BioUtah News | Comments Off on University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings

Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection […]

Posted in BioUtah News | Comments Off on Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

CancerVax Reports Successful Initial Mouse Study with Breakthrough Results

First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target many types of cancer Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution study […]

Posted in BioUtah News | Comments Off on CancerVax Reports Successful Initial Mouse Study with Breakthrough Results

TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS

TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover NEW ORLEANS–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits […]

Posted in BioUtah News | Comments Off on TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Via OrthoSpineNews   Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramic biomaterials and silicon nitride medical device innovation, […]

Posted in BioUtah News | Comments Off on SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia’s Sudair Industrial City

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia SALT LAKE CITY, April 2, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoMira […]

Posted in BioUtah News | Comments Off on Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia’s Sudair Industrial City